For more than a decade, we are setting a high standard in quality control of therapeutic nanoparticles, always a step ahead of the trend.
We are now proud to introduce our newly developed method for determining the genome length of therapeutic nanoparticles. This powerful method can precisely measure the size (kb) of the genomic material packaged within individual therapeutic nanoparticles. We believe this method could fulfill the requirements of the regulatory authorities (FDA/EMA) by providing both full/empty ratio and exact genome length with just 3 µl of your product. Click the link below to know more about our new method.
Vironova BioAnalytics is the only GMP-certified Transmission Electron Microscopy (TEM) service provider worldwide, providing analytical support for therapeutic nanoparticle development in accordance with GMP and ICH guidelines.
We perform imaging and analysis at our BSL-II laboratory using our proprietary AI-based software that complies with FDA 21 CFR Part 11. Our software streamlines the analysis process, making the identification and characterization of particles more efficient, unbiased, and accurate.
We collaborate with our partners throughout the product development process, utilizing a TEM-based quantitative approach to determine quality parameters. With a decade of experience, we help our partners make informed decisions, add value, and ensure patient safety worldwide.
A great deal of things are going on in the Vironova group and in the industry, which we trendwatch and follow. Take action and follow us on our social media channels and subscribe to our newsletter to stay up to date!
You can also follow us on Mynewsdesk for relevant news updates.
Join us on social media
© Copyright Vironova 2021, all rights reserved
